Vita Actives, part of Dairygold’s Health and Nutrition business unit, has entered an exclusive B2B partnership with Brudy Technology, a Spanish biotech company known for its validated DHA-based innovations.

This collaboration will bring Brudy’s Tridocosahexaenoína-AOX DHA molecule, backed by over 20 years of research and more than 40 clinical trials, to brands and manufacturers globally, supporting product development for premium nutritional supplements and Foods for Special Medical Purposes (FSMP).

Tridocosahexaenoína-AOX is a triglyceride DHA molecule that has been commercially available as part of BrudyLab’s own branded dietary supplements, FSMP and OTC ranges since 2010. Its omega-3 structure, with a high concentration of DHA at the central Sn-2 position, is designed for superior bioavailability, offering potent antioxidant and anti-inflammatory benefits that have been shown to support visual health, maternal and infant health, and sports nutrition applications.

“We are thrilled to partner with Brudy Technology,” said Deepak Sharma, CEO of Vita Actives. “Their expertise in DHA innovation aligns perfectly with our commitment to delivering cutting-edge, research-backed ingredients to brands in the health and wellness sectors.”
 
The partnership will see Vita Actives launch UbiOmega, a high-concentration DHA product sourced from both fish and algal origins. Featuring Brudy’s Tridocosahexaenoína-AOX triglyceride molecule.
 
Dr. Francisco Gasso Casademunt, CEO of Brudy Technology, added: “For over two decades, Brudy Technology has been at the forefront of DHA research, developing formulations that provide real, scientifically proven health benefits. Our Tridocosahexaenoína-AOX® molecule has been the cornerstone of our success, helping millions of consumers through products that support eye health, fertility, maternal health and overall well-being. In partnering with Vita Actives, we are excited to bring our technology to a broader audience in the dietary supplement industry. Their global reach and shared commitment to innovation make them the ideal partner for us.”